Present state of contrast media as related to thromboembolic complications

Role of ADP and thromboxanes in human thrombus formation in ex vivo models.

Platelets·2006

The discovery of factor V: a tricky clotting factor.

Journal of thrombosis and haemostasis : JTH·2003

Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality.

European heart journal·2000

Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia.

Blood·2000

Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.

Acta radiologica (Stockholm, Sweden : 1987)·1998

Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood.

Acta radiologica (Stockholm, Sweden : 1987)·1998

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

Seminars in hematology·2026

The current state of cerebral complications of sickle cell disease.

Seminars in hematology·2026

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

Seminars in hematology·2026

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Seminars in hematology·2026

Germline predisposition in myeloproliferative neoplasms.

Seminars in hematology·2026

Selective Kv1.3 inhibition promotes M2 microglial polarization, accelerates hematoma resolution, and improves neurological recovery following collagenase-induced spontaneous intracerebral hemorrhage in mice.

Veterinary world·2026

Effect of Blood Group on von Willebrand Factor Antigen Levels in Compensated Advanced Chronic Liver Disease and Utility of von Willebrand Factor-Platelet Ratio for Detecting Clinically Significant Portal Hypertension.

Journal of clinical and experimental hepatology·2026

Persistent ALT Elevation and Liver Outcomes After DAA-Induced HCV Cure in People With HIV: Impact of HBV and HDV Co-Infections.

Journal of viral hepatitis·2026

A Common Language for the Multidisciplinary Team: Point-of-Care Musculoskeletal Ultrasound in Modern Haemophilia Care.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Ferritin Normalization Is Not Disease Control in HFE-Related Hemochromatosis: Residual Risk, Transferrin Saturation, and the Hepcidin-Ferroportin Axis.

European journal of haematology·2026

The contemporary role of stereotactic radiosurgery for surgically inoperable cerebral arteriovenous malformations.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Related Experiment Videos

Present state of contrast media as related to thromboembolic complications

Related Concept Videos

Role of ADP and thromboxanes in human thrombus formation in ex vivo models.

The discovery of factor V: a tricky clotting factor.

Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality.

Homozygous truncation of the fibrinogen A alpha chain within the coiled coil causes congenital afibrinogenemia.

Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.

Iohexol, platelet activation and thrombosis. I. Iohexol-induced platelet secretion does not affect thrombus formation in native blood.

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

The current state of cerebral complications of sickle cell disease.

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Management of myeloproliferative neoplasms in pregnancy: Essential thrombocythemia, polycythemia vera, and primary myelofibrosis.

Germline predisposition in myeloproliferative neoplasms.

Selective Kv1.3 inhibition promotes M2 microglial polarization, accelerates hematoma resolution, and improves neurological recovery following collagenase-induced spontaneous intracerebral hemorrhage in mice.

Effect of Blood Group on von Willebrand Factor Antigen Levels in Compensated Advanced Chronic Liver Disease and Utility of von Willebrand Factor-Platelet Ratio for Detecting Clinically Significant Portal Hypertension.

Persistent ALT Elevation and Liver Outcomes After DAA-Induced HCV Cure in People With HIV: Impact of HBV and HDV Co-Infections.

A Common Language for the Multidisciplinary Team: Point-of-Care Musculoskeletal Ultrasound in Modern Haemophilia Care.

Ferritin Normalization Is Not Disease Control in HFE-Related Hemochromatosis: Residual Risk, Transferrin Saturation, and the Hepcidin-Ferroportin Axis.

The contemporary role of stereotactic radiosurgery for surgically inoperable cerebral arteriovenous malformations.

Related Experiment Videos

Present state of contrast media as related to thromboembolic complications

Related Concept Videos

Related Articles